Back
to sessions
Sep 30
Quick Pitch
MODERATOR(S)
David Qian, MD, PhD - MD Anderson Cancer Center
Shahed Badiyan, MD - University of Texas Southwestern Medical Center
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
08:00am - 08:05am ETSpeaker: Shahed Badiyan, MD - University of Texas Southwestern Medical Center, Dallas
-
08:05am - 08:10am ET
Impact of Risk of New-Lesion Progression on Benefit of Local Consolidative Therapy in Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer
Speaker: Hongru Chen, - Fudan University Shanghai Cancer Center, Shanghai -
08:10am - 08:15am ET
-
08:10am - 08:15am ET
-
08:15am - 08:20am ET
Are Some "New" Lung Metastases Already Present at Baseline? An Artificial Intelligence-Based Re-evaluation in Patients Undergoing Lung SBRT for Oligometastases
Speaker: Heejoo Ko, MD, BS - College of Medicine, The Catholic University of Korea, Seoul -
08:20am - 08:25am ET
Feasibility of Aumolertinib followed by SRT in EGFR+ NSCLC Patients with Intracranial Oligo-Progression: A Phase II, Prospective Study
Speaker: Jiayan Chen, MD - Fudan University Shanghai Cancer Center, Shanghai -
08:25am - 08:30am ET
Feasibility and Short-Term Outcomes after One Fraction, Simulation-Free CT-Guided Stereotactic Adaptive Radiotherapy for Patients with Oligometastatic and Primary Lung Tumors (ONE STOP)
Speaker: Alden D'Souza, MD, MPHS - Washington University School of Medicine, Saint Louis -
08:30am - 08:35am ET
Immuno-EclipseRT (iERT): An Immune-Adaptive Heterogeneous Radiotherapy Strategy Triggers XCL1<sup>+ </sup>NK-driven CD8? T Cell Immunity Against Bulky Tumors
Speaker: Ren Luo, MD, PhD - West China Hospital of Sichuan University, Chengdu -
08:35am - 08:55am ETSpeaker: David Qian, MD, PhD - MD Anderson Cancer Center, Houston
-
08:55am - 09:00am ETSpeaker: Shahed Badiyan, MD - University of Texas Southwestern Medical Center, Dallas